ertiprotafib has been researched along with pioglitazone in 1 studies
Studies (ertiprotafib) | Trials (ertiprotafib) | Recent Studies (post-2010) (ertiprotafib) | Studies (pioglitazone) | Trials (pioglitazone) | Recent Studies (post-2010) (pioglitazone) |
---|---|---|---|---|---|
16 | 1 | 8 | 4,338 | 824 | 2,277 |
Protein | Taxonomy | ertiprotafib (IC50) | pioglitazone (IC50) |
---|---|---|---|
CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1 | |
Bile salt export pump | Rattus norvegicus (Norway rat) | 2 | |
Peroxisome proliferator-activated receptor gamma | Rattus norvegicus (Norway rat) | 0.7 | |
Bile salt export pump | Homo sapiens (human) | 0.337 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 0.114 | |
Steryl-sulfatase | Homo sapiens (human) | 0.8 | |
Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 1.15 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.298 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.0379 | |
Peroxisome proliferator-activated receptor gamma | Mus musculus (house mouse) | 0.7 | |
CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 4.8 | |
CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 8.65 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattarai, BR; Cho, H; Ham, SW; Han, IO; Hwang, JS; Kafle, B; Kang, JS; Khadka, D; Lee, SM; Park, H | 1 |
1 other study(ies) available for ertiprotafib and pioglitazone
Article | Year |
---|---|
Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
Topics: Animals; Anti-Obesity Agents; Binding Sites; Blood Glucose; Catalytic Domain; Computer Simulation; Enzyme Inhibitors; Hypoglycemic Agents; Mice; Phenyl Ethers; PPAR gamma; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Thiazolidinediones | 2009 |